DESCRIPTION
VIVITRA (Trastuzumab) is used in the treatment of breast cancer and stomach cancer. It is a humanized monoclonal anti-HER2 (Human epidermal growth factor receptor 2) antibody. It triggers body’s immune system – NK (Natural Killer) cells to destroy cancer cells. VIVITRA is prescription drug.
Manufacturer : Zydus Cadila Healthcare Limited
SIDE EFFECTS
Side effects : Common side effects are Nausea, Headache, Rash, Reduced blood platelets, Congestive cardiac failure, Insomnia (difficulty in sleeping), Infection, Upper respiratory tract infection, Nasopharyngitis, Fatigue, Fever, Anemia, Chills, Diarrhoea, Cough, Weight loss, Altered taste, Mucosal inflammation, Decreased white blood cell count (neutrophils), Stomatitis (Inflammation of the mouth).
Reviews
There are no reviews yet.